ロード中...
Activity of Praziquantel Enantiomers and Main Metabolites against Schistosoma mansoni
A racemic mixture of R and S enantiomers of praziquantel (PZQ) is currently the treatment of choice for schistosomiasis. Though the S enantiomer and the metabolites are presumed to contribute only a little to the activity of the drug, in-depth side-by-side studies are lacking. The aim of this study...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4135865/ https://ncbi.nlm.nih.gov/pubmed/24982093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02741-14 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|